Home Top News BioNTech Expects to Know About New Variant Vaccine Efficacy in 14 Days

BioNTech Expects to Know About New Variant Vaccine Efficacy in 14 Days

0
BioNTech Expects to Know About New Variant Vaccine Efficacy in 14 Days

BioNTech, which makes Covid-19 vaccines together with Pfizer, said it expects to have more information on the B.1.1.529 variant in the next two weeks.

the lineage B.1.1.529 of the new coronavirus has scientists worried because it has many mutations that give the virus advantages.

The strain is also found in Botswana, South Africa, Hong Kong, Israel and Belgium. So far, there are no records of the variant in Brazil.

“We understand the concerns of experts and immediately begin investigations into the B.1.1.529 variant,” BioNTech said in a statement.

“We hope to have more information from the laboratories in at least two weeks. These data will provide more information on whether B.1.1.529 could be an escape variant that would require adjustments to the vaccine if it spreads globally,” the statement said.

Immune escape variants are those that escape the protection offered by vaccines. If this is the case with the new variant, the laboratory says it hopes to be able to adjust the vaccine in six weeks and deliver the first doses of the new version within 100 days,

* With information from Reuters

Reference: CNN Brasil

NO COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here